NCT03500900View on ClinicalTrials.gov

Vildagliptin on Gastric Accommodation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions
Healthy
Interventions
DRUG

Vildagliptin 50 mg

Acute administration of Vildagliptin, 50 mg.

DRUG

Placebo Oral Tablet

Acute administration of placebo tablet

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03500900 - Vildagliptin on Gastric Accommodation | Biotech Hunter | Biotech Hunter